Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

Recruiting

FARAFLEX Mapping & PFAEvaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

Sponsor:

Boston Scientific Corporation

Code:

NCT07575269

Conditions

Paroxysmal Atrial Fibrillation (PAF)

Persistent Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FARAFLEX Mapping and Pulsed Field Ablation (PFA) System

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-13. This information was provided to ClinicalTrials.gov by Boston Scientific Corporation on 2026-08-06.